Free Trial
NYSE:CHRO

Chromocell Therapeutics (CHRO) Stock Price, News & Analysis

Chromocell Therapeutics logo
$1.34 +0.08 (+6.35%)
Closing price 07/1/2025
Extended Trading
$1.34 0.00 (0.00%)
As of 07/1/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chromocell Therapeutics Stock (NYSE:CHRO)

Key Stats

Today's Range
$1.23
$1.48
50-Day Range
$1.34
$13.50
52-Week Range
$4.50
$38.00
Volume
194,032 shs
Average Volume
45,226 shs
Market Capitalization
$8.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CHRO Stock News Headlines

Gold buying hits 4-year high
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an epic bull rally in gold. JP Morgan and Goldman Sachs have a price target of $4,000. My research tells me gold could surpass $5,000 in the coming months. Folks using a very specific gold strategy since the 80s could have made more than 60 TIMES their money. Today, you can take advantage of a similar setup for around $10
Ligand subsidiaries, Chromocell Therapeutics to merge
Chromocell Therapeutics Corp (CHRO)
Channel Therapeutics Corporation (CHRO)
See More Headlines

CHRO Stock Analysis - Frequently Asked Questions

Chromocell Therapeutics' stock was trading at $6.41 at the start of the year. Since then, CHRO shares have decreased by 79.1% and is now trading at $1.34.

Shares of Chromocell Therapeutics reverse split before market open on Wednesday, July 2nd 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Chromocell Therapeutics (CHRO) raised $7 million in an IPO on Friday, February 16th 2024. The company issued 1,100,000 shares at $6.00 per share.

Shares of CHRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CHRO
Previous Symbol
NYSE:CHRO
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.38 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($1.65) per share
Price / Book
-0.81

Miscellaneous

Free Float
5,039,000
Market Cap
$8.69 million
Optionable
N/A
Beta
3.63
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:CHRO) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners